Caspase-1–dependent pyroptosis converts αSMA + CAFs into collagen-III high iCAFs to fuel chemoresistant cancer stem cells
Science Advances · 13.06.2025 · 11 (24)
DOI: 10.1126/sciadv.adt8697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 13.06.2025. Verfasst von Hongbo Gao und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Methodist Neal Cancer Center, Houston Methodist Research Institute, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Pyroptosis, Neoplastic Stem Cells, Drug Resistance, Neoplasm, Cancer-Associated Fibroblasts. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, U.S. Department of Defense, National Cancer Institute.
Abstract (Originalsprache)
The impact of chemotherapy-induced tumor cell pyroptosis on fibroblasts, a key stromal cell type within the tumor microenvironment (TME), remains unexplored. Here, we report morphologically and molecularly distinct subtypes of cancer-associated fibroblasts (CAFs) in bladder cancer, including αSMA + IL-6 − myofibroblastic CAFs (myCAFs), αSMA − IL-6 + inflammatory CAFs (iCAFs), and hybrid i/myCAFs. Caspase-1–dependent tumor pyroptosis releases several inflammatory chemokines, converting αSMA + CAF into iCAFs in a CCR6-dependent manner. This is clinically relevant, as a fibroblast gene signature driven by iCAF markers and collagen type III is enriched in patients with chemoresistant bladder cancer after neoadjuvant chemotherapy. Contrary to the current notion, iCAFs, rather than myCAFs, produce collagen III in response to chemotherapy, supporting the expansion of cancer stem cells (CSCs). Thus, tumor cell pyroptosis initiates an iCAF-CSC feedforward loop that drives chemoresistance, indicating that inflammatory cell death is not universally beneficial to anticancer therapy, depending on the target cell type.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Methodist Neal Cancer Center, Houston Methodist Research Institute, Houston, TX 77030, USA.
- Graduate Institute of Medical SciencesGraduate Institute of Medical Sciences, Taipei Medical University, Taipei City, Taiwan.
- Department of Pathology, Stanford University, Stanford, CA 94305, USA.
- Graduate Program in Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
- Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
- Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
ORCID-Profile: Hongbo Gao, Stephen Q R Wong, Ethan Subel, Yung Hsing Huang, Yu-Cheng Lee, Kazukuni Hayashi, Mark Ellie Alonzo, Xen Ping Hoi, Steven Shen, Fotis Nikolos, Keith Syson Chan
Förderung
- NCI NIH HHS
- U.S. Department of Defense
- National Cancer Institute
- Cancer Prevention and Research Institute of Texas
Zitieren
APA
Gao, H., Wong, S. Q. R., Subel, E., Huang, Y. H., Lee, Y. C., Hayashi, K., Alonzo, M. E., Karabicici, M., Hoi, X. P., Kasabyan, A., Mo, Q., Melchiode, Z., El-Zaatari, Z., Shen, S., Satkunasivam, R., Nikolos, F., & Chan, K. S. (2025). Caspase-1–dependent pyroptosis converts αSMA + CAFs into collagen-III high iCAFs to fuel chemoresistant cancer stem cells. Science Advances, 11(24). https://doi.org/10.1126/sciadv.adt8697
Vancouver
Gao H, Wong SQR, Subel E, Huang YH, Lee YC, Hayashi K, et al. Caspase-1–dependent pyroptosis converts αSMA + CAFs into collagen-III high iCAFs to fuel chemoresistant cancer stem cells. Science Advances. 2025;11(24). doi:10.1126/sciadv.adt8697
BibTeX
@article{Gao2025,
author = {Gao, Hongbo and Wong, Stephen Q R and Subel, Ethan and Huang, Yung Hsing and Lee, Yu-Cheng and Hayashi, Kazukuni and Alonzo, Mark Ellie and Karabicici, Mustafa and Hoi, Xen Ping and Kasabyan, Armine and Mo, Qianxing and Melchiode, Zachary and El-Zaatari, Ziad and Shen, Steven and Satkunasivam, Raj and Nikolos, Fotis and Chan, Keith Syson},
title = {Caspase-1–dependent pyroptosis converts αSMA + CAFs into collagen-III high iCAFs to fuel chemoresistant cancer stem cells},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {24},
doi = {10.1126/sciadv.adt8697}
}
EUVIMED